로딩 중…
지수 로딩 중…
NovoCure Limited
NVCR· NASDAQ· Health Care· Health Care Equipment & Services
JE
$16.72+3.08%
2026-09-17
Financials
Valuation Metrics
NovoCure Limited's Market Cap is $1.94B. At end of 2025 it was $1.44B. Ranked #2054 of 3,121 in US market (top 66%), #793 of 1,463 on NASDAQ (top 54%), #123 of 205 in Health Care Equipment & Services (top 60%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.94B | US#2,054/3,121 Sec#123/205 |
| Revenue | $699M | US#2,108/3,121 Sec#130/205 |
| Net Income | $-149M | US—/3,121 Sec—/205 |
| Total Assets | $795M | US#2,574/3,121 Sec#137/205 |
| Net Assets | $338M | US#2,474/3,121 Sec#139/205 |
| Value | ||
| P/B | 5.73x | US#2,320/3,121 Sec#140/205 |
| P/S | 2.77x | US#1,604/3,121 Sec#113/205 |
| FCF Yield | -1.09% | US—/3,121 Sec—/205 |
| Profitability | ||
| ROE | -43.94% | US#2,652/3,121 Sec#167/205 |
| ROA | -18.68% | US#2,782/3,121 Sec#174/205 |
| Op. Margin | -22.08% | US#2,613/3,121 Sec#167/205 |
| Revenue Growth | 10.95% | US#1,192/3,121 Sec#82/205 |
| Financial Health | ||
| Debt Ratio | 135.20% | US#1,390/3,121 Sec#127/205 |
| Total Debt | $233M | US#2,207/3,121 Sec#120/205 |
| FCF | $-21M | US#2,431/3,121 Sec#160/205 |
| Cash | $94M | US#2,268/3,121 Sec#142/205 |
| Current Ratio | 2.89x | US#836/3,121 Sec#83/205 |
| Performance | ||
| 1Y Return | 31.76% | US#880/3,121 Sec#71/205 |
| 1M Return | -3.02% | US#1,380/3,121 Sec#118/205 |
| From 52W High | -22.05% | US#1,623/3,121 Sec#113/205 |
| 1Y MDD | -32.55% | US#1,597/3,121 Sec#79/205 |
| Trading | ||
| Volume | 1,135,879 shares | US#1,291/3,121 Sec#80/205 |
| Trading Value | $19M | US#1,910/3,121 Sec#130/205 |
| Per Share | ||
| EPS | $-1.28 | US—/3,121 Sec—/205 |
| BPS | $2.92 | US#2,504/3,121 Sec#164/205 |